Breaking News Instant updates and real-time market news.

CNX

CNX Resources

$10.53 /

+0.39 (+3.85%)

06:10
09/08/20
09/08
06:10
09/08/20
06:10

CNX Resources raises FY20 FCF view to $350M from $300M

CNX Resources announced that it continues to execute on its commitment to generate free cash flow, or FCF, per share on a regular basis and reducing its outstanding debt. The following is an update of key drivers in that effort.. The company increased 2020 FCF guidance to approximately $350M from prior guidance of $300M. In August, CNX received $104M of federal tax refunds, which the company expects to use to further pay down its 5.875% notes due in 2022, leaving a remaining balance of approximately $250M, a reduction from $895M at year-end 2019. CNX expects full year EBITDAX to be modestly above the high-end of the previously announced range of $830M-$900M.Capital expenditures expected near the midpoint of the previously announced range of $470M-$550M. Previously curtailed production expected to resume October 1. The company estimates that optimizing the temporary curtailments and turning back in-line timings have resulted in approximately $30M of net present value realized through the pricing arbitrage

CNX CNX Resources
$10.53 /

+0.39 (+3.85%)

08/17/20
Fly Intel: Top five analyst downgrades
08/17/20 MKM Partners
CNX Resources downgraded to Neutral from Buy at MKM Partners
08/12/20
CNX Resources upgraded to Overweight at Piper Sandler after FCF outlook
08/12/20 Piper Sandler
CNX Resources upgraded to Overweight from Neutral at Piper Sandler

TODAY'S FREE FLY STORIES

Hot Stocks
Capital Senior Living announces CFO Carey Hendrickson will step down » 16:13
09/21/20
09/21
16:13
09/21/20
16:13
CSU

Capital Senior Living

$0.64 /

-0.015 (-2.31%)

Capital Senior Living…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSU Capital Senior Living
$0.64 /

-0.015 (-2.31%)

CSU Capital Senior Living
$0.64 /

-0.015 (-2.31%)

Earnings
Kforce raises Q3 EPS greater than 82c per share, consensus 76c » 16:11
09/21/20
09/21
16:11
09/21/20
16:11
KFRC

Kforce

$32.36 /

-1.29 (-3.83%)

Sees Q3 revenue greater…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KFRC Kforce
$32.36 /

-1.29 (-3.83%)

KFRC Kforce
$32.36 /

-1.29 (-3.83%)

08/11/20 Truist
Kforce price target raised to $35 from $30 at Truist
08/11/20 William Blair
Kforce upgraded to Outperform from Market Perform at William Blair
05/28/20 Sidoti
Kforce downgraded to Neutral from Buy at Sidoti
03/03/20 Sidoti
Kforce initiated with a Buy at Sidoti
KFRC Kforce
$32.36 /

-1.29 (-3.83%)

KFRC Kforce
$32.36 /

-1.29 (-3.83%)

Hot Stocks
Parsons selected for three task orders totaling $69M » 16:11
09/21/20
09/21
16:11
09/21/20
16:11
PSN

Parsons

$35.20 /

-0.53 (-1.48%)

Parsons has been selected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$35.20 /

-0.53 (-1.48%)

PSN Parsons
$35.20 /

-0.53 (-1.48%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
PSN Parsons
$35.20 /

-0.53 (-1.48%)

PSN Parsons
$35.20 /

-0.53 (-1.48%)

Hot Stocks
Silk Road names Buchanan COO, appoints William Whealon EVP research » 16:09
09/21/20
09/21
16:09
09/21/20
16:09
SILK

Silk Road Medical

$67.05 /

-2.68 (-3.84%)

Silk Road Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SILK Silk Road Medical
$67.05 /

-2.68 (-3.84%)

SILK Silk Road Medical
$67.05 /

-2.68 (-3.84%)

08/21/20 Piper Sandler
Silk Road Medical initiated with a Neutral at Piper Sandler
08/06/20 SVB Leerink
Silk Road Medical price target raised to $60 from $51 at SVB Leerink
08/06/20 Citi
Silk Road Medical price target raised to $58 from $50 at Citi
07/09/20
Fly Intel: Top five analyst initiations
SILK Silk Road Medical
$67.05 /

-2.68 (-3.84%)

  • 06
    May
SILK Silk Road Medical
$67.05 /

-2.68 (-3.84%)

Hot Stocks
CAE launches new digital platform for pilots called Airside » 16:09
09/21/20
09/21
16:09
09/21/20
16:09
CAE

CAE

$14.34 /

-0.73 (-4.84%)

CAE announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAE CAE
$14.34 /

-0.73 (-4.84%)

CAE CAE
$14.34 /

-0.73 (-4.84%)

08/14/20 TD Securities
CAE price target raised to C$21 from C$20 at TD Securities
08/13/20 RBC Capital
CAE price target lowered to C$27 from C$28 at RBC Capital
08/13/20 Scotiabank
CAE price target raised to C$30 from C$29 at Scotiabank
08/13/20 Scotiabank
CAE upgraded to Outperform from Sector Perform at Scotiabank
CAE CAE
$14.34 /

-0.73 (-4.84%)

Hot Stocks
ADC Therapeutics submits BLA to FDA for Loncastuximab in DLBCL » 16:08
09/21/20
09/21
16:08
09/21/20
16:08
ADCT

ADC Therapeutics

$44.85 /

-0.675 (-1.48%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADCT ADC Therapeutics
$44.85 /

-0.675 (-1.48%)

ADCT ADC Therapeutics
$44.85 /

-0.675 (-1.48%)

06/09/20 Morgan Stanley
ADC Therapeutics initiated with an Overweight at Morgan Stanley
06/09/20 Cowen
ADC Therapeutics initiated with an Outperform at Cowen
06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA
06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA
ADCT ADC Therapeutics
$44.85 /

-0.675 (-1.48%)

  • 15
    May
  • 03
    Oct
ADCT ADC Therapeutics
$44.85 /

-0.675 (-1.48%)

Hot Stocks
Reliant Bancorp CAO Kowalski resigns » 16:06
09/21/20
09/21
16:06
09/21/20
16:06
RBNC

Reliant Bancorp

$14.07 /

-0.56 (-3.83%)

Reliant Bancorp announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBNC Reliant Bancorp
$14.07 /

-0.56 (-3.83%)

RBNC Reliant Bancorp
$14.07 /

-0.56 (-3.83%)

06/09/20 Raymond James
Reliant Bancorp initiated with a Market Perform at Raymond James
04/30/20 Janney Montgomery Scott
Reliant Bancorp upgraded to Buy on better margins at Janney Montgomery Scott
04/30/20 Janney Montgomery Scott
Reliant Bancorp upgraded to Buy from Neutral at Janney Montgomery Scott
04/06/20 Piper Sandler
Reliant Bancorp upgraded to Overweight from Neutral at Piper Sandler
RBNC Reliant Bancorp
$14.07 /

-0.56 (-3.83%)

Hot Stocks
Fortune Brands announces $500M buyback » 16:05
09/21/20
09/21
16:05
09/21/20
16:05
FBHS

Fortune Brands

$82.24 /

-2.02 (-2.40%)

Fortune Brands announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBHS Fortune Brands
$82.24 /

-2.02 (-2.40%)

09/10/20 KeyBanc
Fortune Brands upgraded to Overweight with $95 target at KeyBanc
09/10/20 KeyBanc
Fortune Brands upgraded to Overweight from Sector Weight at KeyBanc
08/04/20 Loop Capital
American Woodmark price target raised to $97 from $79 at Loop Capital
07/30/20 Credit Suisse
Fortune Brands price target raised to $83 from $70 at Credit Suisse
FBHS Fortune Brands
$82.24 /

-2.02 (-2.40%)

FBHS Fortune Brands
$82.24 /

-2.02 (-2.40%)

FBHS Fortune Brands
$82.24 /

-2.02 (-2.40%)

Hot Stocks
Inari says interim results from the FLASH study to be presented at TCT Connect » 16:04
09/21/20
09/21
16:04
09/21/20
16:04
NARI

Inari Medical

$64.13 /

-3.07 (-4.57%)

Inari Medica announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NARI Inari Medical
$64.13 /

-3.07 (-4.57%)

NARI Inari Medical
$64.13 /

-3.07 (-4.57%)

08/12/20 Morgan Stanley
Inari Medical price target raised to $66 from $52 at Morgan Stanley
08/12/20 Canaccord
Inari Medical price target raised to $73 from $60 at Canaccord
06/19/20 Canaccord
Inari Medical initiated with a Buy at Canaccord
06/16/20 Morgan Stanley
Inari Medical initiated with an Equal Weight at Morgan Stanley
NARI Inari Medical
$64.13 /

-3.07 (-4.57%)

  • 22
    May
NARI Inari Medical
$64.13 /

-3.07 (-4.57%)

NARI Inari Medical
$64.13 /

-3.07 (-4.57%)

Syndicate
Protara Therapeutics announces offerings of common, preferred stock » 16:02
09/21/20
09/21
16:02
09/21/20
16:02
TARA

Protara Therapeutics

$16.50 /

-2.85 (-14.73%)

Protara Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TARA Protara Therapeutics
$16.50 /

-2.85 (-14.73%)

TARA Protara Therapeutics
$16.50 /

-2.85 (-14.73%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Guggenheim
Protara Therapeutics started with Buy rating, $50 target at Guggenheim
07/29/20 Guggenheim
Protara Therapeutics initiated with a Buy at Guggenheim
01/22/20 Ladenburg
ArTara Therapeutics initiated with a Buy at Ladenburg
TARA Protara Therapeutics
$16.50 /

-2.85 (-14.73%)

Conference/Events
Amgen to host business news update conference call » 15:55
09/21/20
09/21
15:55
09/21/20
15:55
AMGN

Amgen

$242.00 /

-5.94 (-2.40%)

Management provides an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$242.00 /

-5.94 (-2.40%)

AMGN Amgen
$242.00 /

-5.94 (-2.40%)

08:53 Today JonesTrading
Mirati Therapeutics price target raised to $200 from $150 at JonesTrading
07:10 Today Cantor Fitzgerald
Amgen's updated Kras data support accelerated path, says Cantor Fitzgerald
09/20/20 Piper Sandler
Amgen's sotorasib update 'Incrementally positive,' says Piper Sandler
09/18/20 Piper Sandler
Amgen sotosarib Phase 1 data a good news/bad news event, says Piper Sandler
AMGN Amgen
$242.00 /

-5.94 (-2.40%)

AMGN Amgen
$242.00 /

-5.94 (-2.40%)

AMGN Amgen
$242.00 /

-5.94 (-2.40%)

AMGN Amgen
$242.00 /

-5.94 (-2.40%)

Periodicals
Activist Trian sees Comcast as undervalued, takes $870M stake, WSJ says » 15:54
09/21/20
09/21
15:54
09/21/20
15:54
CMCSA

Comcast

$43.73 /

-1.53 (-3.38%)

Activist investor Nelson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMCSA Comcast
$43.73 /

-1.53 (-3.38%)

CMCSA Comcast
$43.73 /

-1.53 (-3.38%)

09/18/20 Rosenblatt
Rosenblatt would be buyer on any Roku weakness amid latest Comcast 'tiff'
09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
08/24/20 BWS Financial
Xperi initiated with a Buy at BWS Financial
08/03/20 Deutsche Bank
Comcast price target raised to $53 from $47 at Deutsche Bank
CMCSA Comcast
$43.73 /

-1.53 (-3.38%)

CMCSA Comcast
$43.73 /

-1.53 (-3.38%)

CMCSA Comcast
$43.73 /

-1.53 (-3.38%)

CMCSA Comcast
$43.73 /

-1.53 (-3.38%)

Periodicals
Activist investor Trian takes stake in Comcast, WSJ reports  15:51
09/21/20
09/21
15:51
09/21/20
15:51
CMCSA

Comcast

$43.75 /

-1.51 (-3.34%)

 
ShowHide Related Items >><<
CMCSA Comcast
$43.75 /

-1.51 (-3.34%)

CMCSA Comcast
$43.75 /

-1.51 (-3.34%)

09/18/20 Rosenblatt
Rosenblatt would be buyer on any Roku weakness amid latest Comcast 'tiff'
09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
08/24/20 BWS Financial
Xperi initiated with a Buy at BWS Financial
08/03/20 Deutsche Bank
Comcast price target raised to $53 from $47 at Deutsche Bank
CMCSA Comcast
$43.75 /

-1.51 (-3.34%)

CMCSA Comcast
$43.75 /

-1.51 (-3.34%)

CMCSA Comcast
$43.75 /

-1.51 (-3.34%)

CMCSA Comcast
$43.75 /

-1.51 (-3.34%)

Periodicals
PJT Partners hired by lenders of LA Fitness to lead debt discussions, WSJ says » 15:35
09/21/20
09/21
15:35
09/21/20
15:35
PJT

PJT Partners

$56.79 /

-2.41 (-4.07%)

Lenders to the LA Fitness…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PJT PJT Partners
$56.79 /

-2.41 (-4.07%)

07/22/20 Wolfe Research
PJT Partners initiated with an Outperform at Wolfe Research
02/06/20 JMP Securities
PJT Partners price target raised to $59 from $54 at JMP Securities
PJT PJT Partners
$56.79 /

-2.41 (-4.07%)

  • 13
    Feb
Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 15:17
09/21/20
09/21
15:17
09/21/20
15:17

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 15:17
09/21/20
09/21
15:17
09/21/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
09/21/20
09/21
15:16
09/21/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 15:14
09/21/20
09/21
15:14
09/21/20
15:14

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Illumina downgraded to Neutral after deal for Grail at JPMorgan » 15:12
09/21/20
09/21
15:12
09/21/20
15:12
ILMN

Illumina

$269.21 /

-26.08 (-8.83%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

15:07 Today JPMorgan
Illumina downgraded to Neutral from Overweight at JPMorgan
14:33 Today Cowen
Illumina's GRAIL deal 'an unclear fit' with core competencies, says Cowen
06:11 Today Guggenheim
Illumina upgraded to Buy from Neutral at Guggenheim
09/17/20 Citi
Citi does not see strategic rationale in Illumina acquiring Grail
ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

Downgrade
Illumina downgraded to Neutral from Overweight at JPMorgan » 15:07
09/21/20
09/21
15:07
09/21/20
15:07
ILMN

Illumina

$267.88 /

-27.41 (-9.28%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

14:33 Today Cowen
Illumina's GRAIL deal 'an unclear fit' with core competencies, says Cowen
06:11 Today Guggenheim
Illumina upgraded to Buy from Neutral at Guggenheim
09/17/20 Citi
Citi does not see strategic rationale in Illumina acquiring Grail
09/09/20 Morgan Stanley
Illumina initiated with an Equal Weight at Morgan Stanley
ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

Conference/Events
Stamps.com participates in a conference call with Craig-Hallum » 15:06
09/21/20
09/21
15:06
09/21/20
15:06
STMP

Stamps.com

$219.35 /

-6.54 (-2.90%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

08/07/20 Northland
Stamps.com downgraded to Market Perform from Outperform at Northland
08/07/20 Craig-Hallum
Stamps.com price target raised to $340 from $300 at Craig-Hallum
08/03/20 Craig-Hallum
Stamps.com price target raised to $300 from $230 at Craig-Hallum
05/28/20 Northland
Northland keeps Outperform on Stamps.com, sees e-commerce volume to persist
STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

Initiation
PNM Resources initiated with a Buy at Sidoti » 15:00
09/21/20
09/21
15:00
09/21/20
15:00
PNM

PNM Resources

$39.32 /

-0.72 (-1.80%)

Sidoti initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNM PNM Resources
$39.32 /

-0.72 (-1.80%)

PNM PNM Resources
$39.32 /

-0.72 (-1.80%)

08/11/20 Wells Fargo
PNM Resources upgraded to Overweight from Equal Weight at Wells Fargo
06/03/20 Mizuho
PNM Resources price target raised to $45 from $43 at Mizuho
05/15/20 Barclays
Barclays upgrades Utilities sector along with PG&E and two others
05/15/20 Barclays
PNM Resources upgraded to Overweight from Equal Weight at Barclays
PNM PNM Resources
$39.32 /

-0.72 (-1.80%)

  • 08
    Jan
Conference/Events
scPharmaceuticals to host conference call » 15:00
09/21/20
09/21
15:00
09/21/20
15:00
SCPH

scPharmaceuticals

$7.50 /

+ (+0.00%)

Management holds a Key…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

05/13/20 SVB Leerink
scPharmaceuticals price target raised to $12 from $7 at SVB Leerink
05/13/20 H.C. Wainwright
scPharmaceuticals price target raised to $15 from $13 at H.C. Wainwright
10/15/19 H.C. Wainwright
scPharmaceuticals initiated with a Buy at H.C. Wainwright
SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

  • 21
    May
SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

Recommendations
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler » 15:00
09/21/20
09/21
15:00
09/21/20
15:00
MRK

Merck

$82.34 /

-3.48 (-4.05%)

, SNY

Sanofi

$50.42 /

-2.01 (-3.83%)

, REGN

Regeneron

$547.45 /

-7.78 (-1.40%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

MRK Merck
$82.34 /

-3.48 (-4.05%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
SNY Sanofi
$50.42 /

-2.01 (-3.83%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink
REGN Regeneron
$547.45 /

-7.78 (-1.40%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

  • 27
    May
MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

Hot Stocks
Ionis' treatment of Alexander disease granted FDA orphan designation » 14:58
09/21/20
09/21
14:58
09/21/20
14:58
IONS

Ionis Pharmaceuticals

$49.54 /

-1.85 (-3.60%)

Ionis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

09/14/20 JPMorgan
Ionis Pharmaceuticals resumed with a Neutral at JPMorgan
09/08/20 Citi
Ionis Pharmaceuticals price target lowered to $74 from $78 at Citi
09/02/20 Benchmark
Benchmark starts Ionis at Hold, cautious on Spinraza competition
09/02/20 Benchmark
Ionis Pharmaceuticals initiated with a Hold at Benchmark
IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.